Comprehensive, Coordinated Care
The Cancer and Blood Diseases Institute at Cincinnati Children's Hospital Medical Center provides expert care for children with newly diagnosed and relapsed neuroblastoma. Our Neuroblastoma Advanced Therapies Center offers patients and families the full spectrum of medical, surgical and diagnostic care, as well as supportive services.
Advancing Targeted Radiation Therapies
Cincinnati Children’s is a leading center for the development and clinical testing of new approaches to neuroblastoma treatment. Our physicians and researchers are actively involved in many national and international research studies, and develop their own research protocols as well. This provides our patients with early access to new anticancer therapies, sometimes years before they become widely available. Such therapies include 131I-MIBG therapy, which targets radiation directly to neuroblastoma cells while sparing healthy tissue. Cincinnati Children’s is one of just a few pediatric centers in the country providing the technically demanding 131I-MIBG therapy, which requires special facilities for radiation safety and a collaborative approach to care across multiple divisions.
Cincinnati Children’s also specializes in blood and marrow transplantation. In fact, our transplant team has performed more than 1,300 blood and marrow transplants, including more than 160 for advanced neuroblastoma. The pediatric Bone Marrow Transplantation Program at Cincinnati Children’s is one of the largest in the country
Innovative Clinical Research
Cincinnati Children's is a major referral center for the National Cancer Institute's two new pediatric research initiatives for children with high-risk neuroblastoma: the Pediatric Phase I Consortium and the New Approaches to Neuroblastoma Therapy Consortium. Many of our physicians serve in leadership positions for these and other pediatric cancer organizations, further strengthening our link to the latest clinical research opportunities.
